Work

CSF proteomics analysis to investigate the pharmacodynamic response of the S2R modulator CT1812 in Alzheimer’s disease patients from the SPARC clinical trial

Year: 2022

Type: article

Source: Alzheimer s & Dementia

DOI: 10.1002/alz.068166

Authors: Kiran Pandey, Lora Waybright, Duc M. Duong, Evi Malagise, Kaj Blennow, Henrik Zetterberg, Adam P Mecca, Christopher H van Dyck, Anthony O Caggiano, Nicholas T. Seyfried, Mary E Hamby

Institutions: Cognition Therapeutics (United States), Emory University, University of Gothenburg, Yale University

Language: English

Topic: Alzheimer's disease research and treatments

Subfield: Physiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4311999302

FWCI: 0.129

Cites:

Cited by: 2

Related to: 10